Prescription drug · ANDA
Paricalcitol NDC 65862-937
Paricalcitol 2 ug/1 · Capsule, Liquid filled · Oral · Aurobindo Pharma Limited
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 65862-937-30 | 65862093730 | 30 CAPSULE, LIQUID FILLED in 1 BOTTLE (65862-937-30)Marketed from Jan 14, 2016 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Paricalcitol
- Generic name (nonproprietary)
- paricalcitol
- Active ingredients
- Paricalcitol — 2 ug/1
- Dosage form
- Capsule, Liquid filled
- Route
- Oral
- Labeler
- Aurobindo Pharma LimitedNDC labeler code 65862
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 207672
- Marketing start
- Listing expires
- Other FDA classes
- Ergocalciferols (Chemical structure)
- Identifiers
- Product ID 65862-937_162204c0-4791-44bc-9c2e-45f354987013SPL ID 162204c0-4791-44bc-9c2e-45f354987013SPL set ID 59738576-3494-4d72-98d2-6904a3778081RxCUI 577315, 577317, 577324UNII 6702D36OG5
- Pharmacologic class
- Vitamin D Analog; Vitamin D2 Analog
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N465862093730followed by a unit qualifier and the quantityPackage 65862-0937-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Paricalcitol is a vitamin D analog indicated in adults and pediatric patients 10 years and older for the prevention and treatment of secondary hyperparathyroidism associated with: Chronic kidney disease (CKD) Stages 3 and 4 (1.1) . CKD Stage 5 in patients on hemodialysis or peritoneal dialysis (1.2) . 1.1 Chronic Kidney Disease Stages 3 and 4 Paricalcitol capsules are indicated in adults and pediatric patients 10 years of age and older for the prevention and treatment of secondary hyperparathyroidism associated with Chronic Kidney Disease (CKD) Stages 3 and 4. 1.2 Chronic Kidney Disease Stage 5 Paricalcitol capsules are indicated in adults and pediatric patients 10 years of age and older for…
Excerpt only. Read the full label for complete information.
About NDC 65862-937
- What is NDC 65862-937?
- 65862-937 is the product NDC for Paricalcitol, Paricalcitol 2 ug/1 capsule, liquid filled, listed with the FDA by Aurobindo Pharma Limited. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Paricalcitol.
- What is the active ingredient?
- Paricalcitol.
- Who is the labeler?
- Aurobindo Pharma Limited, NDC labeler code 65862. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Paricalcitol?
- 32 other product NDCs are listed under this name. See all Paricalcitol NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Paricalcitol products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Paricalcitol | Paricalcitol 2 ug/mL | InjectionIntravenous | Eugia US LLC | 55150-212 | 55150-0212-01 |
| Paricalcitol | Paricalcitol 5 ug/mL | InjectionIntravenous | Eugia US LLC | 55150-213 | 55150-0213-01 |
| Paricalcitol | Paricalcitol 10 ug/2mL | InjectionIntravenous | Eugia US LLC | 55150-214 | 55150-0214-02 |
| Paricalcitol | Paricalcitol 10 ug/2mL | InjectionIntravenous | Eugia US LLC | 55150-215 | 55150-0215-02 |
| Paricalcitol | Paricalcitol 2 ug/mL | InjectionIntravenous | Amneal Pharmaceuticals LLC | 70121-1033 | 70121-1033-0570121-1033-07 |
| Paricalcitol | Paricalcitol 5 ug/mL | InjectionIntravenous | Amneal Pharmaceuticals LLC | 70121-1034 | 70121-1034-0570121-1034-07 |
| Paricalcitol | Paricalcitol 10 ug/2mL | InjectionIntravenous | Amneal Pharmaceuticals LLC | 70121-1035 | 70121-1035-0570121-1035-07 |
| Paricalcitol | Paricalcitol 10 ug/2mL | InjectionIntravenous | Amneal Pharmaceuticals LLC | 70121-1036 | 70121-1036-0570121-1036-07 |
| Paricalcitol | Paricalcitol 1 ug/1 | Capsule, Liquid filledOral | TIME CAP LABORATORIES, INC | 49483-687 | 49483-0687-03 |
| Paricalcitol | Paricalcitol 4 ug/1 | Capsule, Liquid filledOral | TIME CAP LABORATORIES, INC | 49483-689 | 49483-0689-03 |